phase readout
saveNCT06181370: Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
COMPLETEDupdated 10d ago
community read0 votes
Sponsor: Agomab Spain S.L.. Phase: PHASE1. Conditions: IPF
view source ↗
comments(0)
5-min edit window · permanent after that